Advertisement

Milrinone Injection

[29 July 2015]

Products Affected - Description

Milrinone injection, Fresenius Kabi 
1 mg/mL, 20 mL vial, 10 count (NDC 63323-0617-20)
1 mg/mL, 50 mL vial, single count (NDC 63323-0617-50)
 
Milrinone injection, Hospira
1 mg/mL, 10 mL vial, single count (NDC 00409-0212-03)
 
Milrinone injection, West-Ward
0.2 mg/mL, 100 mL premixed bags, 10 count (NDC 00143-9719-10)
0.2 mg/mL, 200 mL premixed bags, 10 count (NDC 00143-9718-10)
1 mg/mL, 50 mL vial, 1 count (NDC 00143-9708-01)
 

Reason for the Shortage

  • Fresenius Kabi states the reason for the shortage is increased demand for the product.
  • Hospira has milrinone injection on shortage due to increased demand.
  • West-Ward states the shortage is due to manufacturing delays.

Available Products

Milrinone injection, Baxter
0.2 mg/mL, 100 mL premixed bags, 10 count (NDC 00338-6010-48)
0.2 mg/mL, 200 mL premixed bags, 10 count (NDC 00338-6011-37)
 
Milrinone injection, Fresenius Kabi
1 mg/mL, 10 mL vial, 10 count (NDC 63323-0617-10)
 
Milrinone injection, Hospira
0.2 mg/mL, 100 mL premixed bags, 10 count (NDC 00409-2776-23)
0.2 mg/mL, 200 mL premixed bags, 10 count (NDC 00409-2776-02)
1 mg/mL, 10 mL vial, 10 count (NDC 00409-0212-01)
1 mg/mL, 20 mL vial, 10 count (NDC 00409-0212-02)
 
Milrinone injection, West-Ward
1 mg/mL, 10 mL vial, 10 count (NDC 00143-9710-10)
1 mg/mL, 20 mL vial, 10 count (NDC 00143-9709-10)
1 mg/mL, 50 mL vial, single count (NDC 00143-9708-01)

Estimated Resupply Dates

  • Fresenius Kabi has milrinone 1 mg/mL 20 mL and 50 mL vials on back order and the company estimates a release date in mid-August 2015.
  • Hospira has milrinone 1 mg/mL 50 mL vials on back order and the company estimates a release date in early-August 2015.
  • West-Ward has milrinone 1 mg/mL 50 mL vials on back order and the company estimates a release date of August to September 2015. Milrinone 0.2 mg/mL 100 mL premix is available with short expiration dating (November 2015) and is on allocation. Milrinone 0.2 mg/mL 200 mL premix is on back order and the company estimates a release date in August 2015.

Related Shortages

Updated

July 29 and 8, June 17 and 1, May 19, April 29, 16 and 15, February 19, January 30, 16 and 9, 2015; December 18 and 1, November 14 and 5, October 2, September 10, August 14 and 1, July 17, 14 and 2, May 30 and 19, April 30, 16 and 1, March 11 and 7, February 14 and 3, January 21, 2014; December 12, November 26 and 15, October 24 and 3, September 12, August 26 and 14, July 9 and 3, June 20, May 8, April 19 and 1, February 7, 2013; December 12, November 15 and 7, October 2, September 12, July 26 and 9, June 21 and 4, May 25 and 9, April 27 and 6, March 22 and 2, February 17, 7 and 1, January 13 and 11, 2012; December 22 and 15, November 11, October 27, 18 and 11, September 23 and 22, August 26, July 29, May 23, April 28 and 14, March 23 and 7, 2011, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement